跳至主要内容
临床试验/NCT01477112
NCT01477112已完成不适用

Effect of the Supplementation With β-carotene to Type 2 Diabetic Patients and Healthy Controls on the Iron Status and Antioxidant Capacity of Plasma

Instituto Venezolano de Investigaciones Cientificas1 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
117
试验地点
1
主要终点
Changes in oxidative status

研究概览

简要总结

Since diabetes has multiple etiologies and oxidative stress one of the proposed mechanisms, the objective is to determine the effect of supplementation with β-carotene to type 2 diabetics and healthy individuals, on iron metabolism, oxidative balance, and antioxidant plasma capacity, using doses similar to the daily nutritional requirement.

详细描述

Type 2 diabetes is a chronic, multifactorial disease, and oxidative stress one of the pathophysiological mechanisms associated with its appearance and development. The objective was to determine the effect of supplementation with β-carotene to type 2 diabetics and healthy individuals, on iron metabolism, oxidative balance, and antioxidant plasma capacity, using doses similar to the daily nutritional requirement.

A total of 117 volunteers participated in the study. Type 2 diabetics (34) and healthy individuals (24), received 6 mg β-carotene for 45 d, and were compared to similar non-supplemented diabetic (33) and control (26) groups. Blood samples were taken at the beginning, end and 30 days after finishing supplementation, to determine hemoglobin, hematocrit unsaturated iron binding capacity, total iron binding capacity, transferrin saturation, ferritin, glycemia, glycosylated hemoglobin, cholesterol, triglycerides, HDL, LDL, oxidized LDL, copper, zinc, TBARS, FRAP, nitrites, GPx, SOD, folates, retinol and β-carotene.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a diagnose of Type 2 diabetes mellitus of at least 5 years of diagnosis, in treatment with oral hypoglycemics Patients in regular control (once a month) in the Hospital

排除标准

  • Hospitalized patient
  • Diabetic patient with diabetes related acute complications (ketoacidosis, hyperosmolar coma)in the 3 months previous to the study.
  • Individuals with infections that required antibiotics in the 3 weeks previous to the study.
  • Individuals with antibodies anti-insulin, autoimmune diseases or in treatment with immunosuppressive drugs.
  • Individuals with viral infections such as hepatitis B, hematological, renal or hepatic diseases.
  • Pregnancy

结局指标

主要结局

Changes in oxidative status

时间窗: Time 0, 45 days and 75 days after supplementation

次要结局

  • Hemoglobin and hematocrit(Time 0, 45 days and 75 days after supplementation)
  • Ferritin(Time 0, 45 days and 75 days after supplementation)
  • Iron metabolism markers(Time 0, 45 days and 75 days after supplementation)
  • Blood Chemistry(Time 0, 45 days and 75 days after supplementation)
  • Glycosylated Hemoglobin(Time 0, 45 days and 75 days after supplementation)
  • Oxidized LDL(Time 0, 45 days and 75 days after supplementation)
  • Thiobarbituric Acid Reactive substances (TBARS)(Time 0, 45 days and 75 days after supplementation)
  • Ferric Reducing ability of Plasma (FRAP).(Time 0, 45 days and 75 days after supplementation)
  • Activities of the enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx).(Time 0, 45 days and 75 days after supplementation)
  • Serum zinc and copper.(Time 0, 45 days and 75 days after supplementation)
  • β-carotene.(Time 0, 45 days and 75 days after supplementation)
  • Serum retinol(Time 0, 45 days and 75 days after supplementation)
  • Serum nitrites(Time 0, 45 days and 75 days after supplementation)
  • Serum and erythrocyte folates.(Time 0, 45 days and 75 days after supplementation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Nieves Garcia-Casal

Director of Pathophysiology Laboratory

Instituto Venezolano de Investigaciones Cientificas

研究点 (1)

Loading locations...

相似试验